$5.8 Billion is the total value of Carlyle Group Inc.'s 10 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 57.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATC | Atotech Ltd | $2,973,567,000 | -11.8% | 153,672,703 | 0.0% | 51.28% | +27.1% | |
| ZI | Sell | ZoomInfo Technologies Inc | $1,385,149,000 | -45.1% | 41,671,145 | -1.4% | 23.89% | -20.9% |
| New | Quidelortho Corp | $1,210,881,000 | – | 12,460,183 | +100.0% | 20.88% | – | |
| VTRU | Vitru Ltd | $109,188,000 | +10.6% | 6,246,471 | 0.0% | 1.88% | +59.6% | |
| ONEM | 1Life Healthcare Inc | $106,723,000 | -29.2% | 13,612,681 | 0.0% | 1.84% | +2.0% | |
| SMHI | Buy | Seacor Marine Hldgs Inc | $6,893,000 | -25.6% | 1,196,649 | +4.2% | 0.12% | +7.2% |
| EM | New | Smart Sh Global Ltdads | $5,339,000 | – | 4,810,209 | +100.0% | 0.09% | – |
| SPNT | SiriusPoint Ltd | $701,000 | -27.6% | 129,408 | 0.0% | 0.01% | 0.0% | |
| New | Meta Data Limitedsponsored ads | $465,000 | – | 314,400 | +100.0% | 0.01% | – | |
| OCDX | Exit | Ortho Clinical Diagnostics H | $0 | – | -118,106,000 | -100.0% | -26.36% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wesco Aircraft Hldgs Inc | 28 | Q4 2019 | 16.8% |
| Seacor Marine Hldgs Inc | 22 | Q3 2023 | 1.1% |
| Enviva Partners LP | 21 | Q2 2020 | 31.5% |
| Enduro Rty Tr | 21 | Q1 2018 | 2.8% |
| USA Compression Partners LP | 20 | Q2 2018 | 28.5% |
| Pattern Energy Group Inc | 20 | Q3 2018 | 16.2% |
| Concord Med Svcs Hldgs Ltd | 19 | Q3 2017 | 1.1% |
| Superior Energy Svcs Inc | 19 | Q3 2017 | 0.7% |
| Cobalt Intl Energy Inc | 17 | Q1 2017 | 11.0% |
| Sequential Brnds Group Inc N | 17 | Q1 2020 | 1.7% |
View Carlyle Group Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Complete Solaria, Inc. | September 22, 2023 | 2,745,879 | 5.7% |
| Carlyle Credit Income Fund | September 14, 2023 | 4,785,628 | 41.0% |
| eFFECTOR Therapeutics, Inc. | August 18, 2023 | 4,829,891 | 7.8% |
| Vera Therapeutics, Inc. | August 02, 2023 | 1,872,764 | 4.2% |
| Reneo Pharmaceuticals, Inc. | May 09, 2023 | 2,730,457 | 8.2% |
| EXICURE, INC. | April 13, 2023 | 287,137 | 3.4% |
| SPRUCE BIOSCIENCES, INC. | February 23, 2023 | 3,734,518 | 9.2% |
| Vaxcyte, Inc. | February 10, 2023 | 2,070,724 | 2.6% |
| NuCana plc | August 11, 2022 | 3,353,134 | 6.4% |
| QuidelOrtho Corp | June 06, 2022 | 12,460,183 | 18.6% |
View Carlyle Group Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| ARS | 2024-04-18 |
| DEF 14A | 2024-04-18 |
| DEFA14A | 2024-04-18 |
| 8-K | 2024-04-03 |
| PRE 14A | 2024-04-03 |
| 4 | 2024-04-02 |
| SC 13G | 2024-03-29 |
| 8-K | 2024-03-27 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Carlyle Group Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.